Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Xyloproct 5%/0.275% Ointment.
| Pharmaceutical Form |
|---|
|
Ointment. |
Composition for: 100 g:
Lidocaine 5 g
Hydrocortisone Acetate micro Ph. Eur. 0.275 g
Excipients with known effect:
Cetyl alcohol (7.4 g per 100 g of ointment)
Stearyl alcohol (0.9 g per 100 g of ointment)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
|
| Lidocaine |
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
| List of Excipients |
|---|
|
Zinc oxide |
Aluminium tube 20 g.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PL 39699/0087
Date of first authorisation: 22 February 1972
Date of latest renewal: 03 April 2003
| Drug | Countries | |
|---|---|---|
| XYLOPROCT | Brazil, Mexico, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
